Barriers to Adherence to Cancer Treatments Among Head and Neck Cancer Patients
Jennifer Lynn Miller, PhD, RN, CMSRN, and Julianne Evers, DNP, APRN, AGACNP-BC, CCRN
From Bellarmine University Department of Nursing, Louisville, Kentucky
Authors’ disclosures of conflicts of interest are found at the end of this article.
Correspondence to: Jennifer Lynn Miller,
PhD, RN, CMSRN, Bellarmine University,
2001 Newburg Road, Louisville, KY 40205
J Adv Pract Oncol 2022;13(5):515–523 |
© 2022 Harborside™
Head and neck cancer patients often undergo a demanding treatment schedule requiring radiation and chemotherapy. Adherence to these treatment schedules is affected by several issues, including socioeconomic factors, characteristics of the disease and treatment plan, symptoms, and side effects. Oncology advanced practitioners (APs) work directly with patients with head and neck cancer (HNC) during active treatment, often screening for and managing side effects and providing referrals. Evidence-based interventions and innovative strategies for the oncology AP to improve HNC patients’ quality of life and treatment adherence include frequent distress screening, AP-led educational interventions and symptom management clinics, and incorporating technology to allow for close contact with patients during treatment.
For access to the full length article, please sign in